Cristina Berastegui
Overview
Explore the profile of Cristina Berastegui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boada-Perez M, Berastegui C, Erro M, Ussetti P, Crespo E, Donadeu L, et al.
Front Immunol
. 2025 Feb;
15:1445553.
PMID: 39911579
Introduction: Risk stratification for CMV infection in lung transplantation (LT) currently relies on determining donor and recipient CMV IgG before transplantation. However, it has been observed that some patients who...
2.
Sempere A, Los-Arcos I, Sacanell J, Berastegui C, Campany-Herrero D, Vima J, et al.
Transpl Int
. 2024 Apr;
37:12579.
PMID: 38605938
Inhaled tobramycin treatment has been associated with nephrotoxicity in some case reports, but limited data are available about serum levels and its possible systemic absorption in lung transplant recipients (LTR)....
3.
Monforte A, Martin-Gomez M, Los-Arcos I, Marquez-Algaba E, Berastegui C, Rosado J, et al.
Transpl Infect Dis
. 2024 Jan;
26(1):e14246.
PMID: 38269450
No abstract available.
4.
Cardona-Pascual I, Pallero M, Berlana D, Villar A, Montoro-Ronsano J, Berastegui C
Respir Med Res
. 2023 Nov;
84:101064.
PMID: 38029650
Background: Tocilizumab is presumed to be an effective and safe treatment for severe SARS-Cov-2, but its usefulness has not been investigated yet for long-term outcomes. This study aimed to evaluate...
5.
Revilla-Lopez E, Ruiz de Miguel V, Lopez-Meseguer M, Berastegui C, Boada-Perez M, Mendoza-Valderrey A, et al.
Front Med (Lausanne)
. 2023 Feb;
10:1079317.
PMID: 36817769
Background: Vascular endothelial growth factor-D (VEGF-D) is the most commonly used biomarker for diagnosing lymphangioleiomyomatosis (LAM). However, lung biopsy is often necessary as well; therefore, defining new biomarkers for LAM...
6.
Loor K, Pallisa E, Culebras M, Deu M, Alvarez A, Sansano I, et al.
Respir Med
. 2023 Feb;
209:107151.
PMID: 36796295
No abstract available.
7.
Riveiro-Barciela M, Roade L, Martinez-Camprecios J, Vidal-Gonzalez J, Rodriguez-Diez B, Perello M, et al.
Gastroenterol Hepatol
. 2023 Feb;
46(10):764-773.
PMID: 36731726
Background: Chronic hepatitis E virus (HEV) in persons with immune impairment has a progressive course leading to a rapid progression to liver cirrhosis. However, prospective data on chronic HEV is...
8.
Riviere A, Picard C, Berastegui C, Mora V, Bunel V, Godinas L, et al.
Am J Transplant
. 2022 Aug;
22(12):2990-3001.
PMID: 35988032
In patients with interstitial lung disease (ILD) complicating classical or amyopathic idiopathic inflammatory myopathy (IIM), lung transplantation outcomes might be affected by the disease and treatments. Here, our objective was...
9.
Loor K, Culebras M, Sansano I, Alvarez A, Sacanell J, Garcia-de-Acilu M, et al.
Eur Respir J
. 2022 Jul;
61(1).
PMID: 35896217
Background: Transbronchial lung cryobiopsy is an emerging technique for diagnosing pulmonary rejection. However, no prospective studies of this procedure for critically ill lung transplant recipients who require mechanical ventilation in...
10.
Bello I, Sandiumenge A, Coll E, de la Torre M, Mosteiro F, Alvarez C, et al.
Arch Bronconeumol
. 2022 Jun;
57(11):720-722.
PMID: 35699020
No abstract available.